• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本某城市帕金森病的流行病学

Epidemiology of Parkinson's disease in a Japanese city.

作者信息

Harada H, Nishikawa S, Takahashi K

出版信息

Arch Neurol. 1983 Mar;40(3):151-4. doi: 10.1001/archneur.1983.04050030045008.

DOI:10.1001/archneur.1983.04050030045008
PMID:6830454
Abstract

A study of the incidence of Parkinson's disease was carried out in a Japanese city, and cases of those who had died were studied to clarify the longevity of the patients and causes of death. On incidence day, April 1, 1980, a total of 101 patients with Parkinson's disease were found to be living in the investigated area, which had a population of 125,291. The incidence rate was 80.6 per 100,000 population, and the average annual incidence for the period 1975 through 1979 was 10.2 per 100,000 population per year. The average age at death was 70.0 years, and the mean duration of illness was 7.4 years. The main causes of death were heart diseases and bronchopneumonia, which were complications of a long period of being bedridden.

摘要

在日本一个城市开展了一项帕金森病发病率的研究,并对已死亡病例进行研究,以明确患者的寿命及死因。在发病日,即1980年4月1日,发现共有101名帕金森病患者生活在被调查区域,该区域人口为125,291人。发病率为每10万人口80.6例,1975年至1979年期间的年均发病率为每10万人口每年10.2例。平均死亡年龄为70.0岁,平均病程为7.4年。主要死因是心脏病和支气管肺炎,这是长期卧床的并发症。

相似文献

1
Epidemiology of Parkinson's disease in a Japanese city.日本某城市帕金森病的流行病学
Arch Neurol. 1983 Mar;40(3):151-4. doi: 10.1001/archneur.1983.04050030045008.
2
Epidemiology of Parkinson's disease in Yonago City, Japan: comparison with a study carried out 12 years ago.日本米子市帕金森病的流行病学:与12年前开展的一项研究的比较。
Neuroepidemiology. 1996;15(4):201-7. doi: 10.1159/000109908.
3
Epidemiology of Parkinson's disease in Finland.芬兰帕金森病的流行病学
Acta Neurol Scand. 1976 Feb;53(2):81-102. doi: 10.1111/j.1600-0404.1976.tb04328.x.
4
Epidemiology of Parkinson's disease in Benghazi, North-East Libya.
Clin Neurol Neurosurg. 1986;88(2):109-13. doi: 10.1016/s0303-8467(86)80005-1.
5
Prognosis of Parkinson's disease in Japan. Tottori University Parkinson's Disease Epidemiology (TUPDE) Study Group.
Eur Neurol. 1997;38 Suppl 2:60-3. doi: 10.1159/000113485.
6
Changes in prevalence and incidence of Parkinson's disease in Japan during a quarter of a century.日本25年间帕金森病患病率和发病率的变化。
Neuroepidemiology. 2009;32(4):263-9. doi: 10.1159/000201565. Epub 2009 Feb 11.
7
Prevalence of Parkinson's disease in Izumo City, Japan.日本出云市帕金森病的患病率。
Gerontology. 1990;36(5-6):340-4. doi: 10.1159/000213219.
8
Parkinson's disease in Taiwan: an analysis of 215 patients.台湾地区帕金森病:215例患者的分析
Neuroepidemiology. 1992;11(3):113-20. doi: 10.1159/000110920.
9
Epidemiology of Parkinson's disease--an overview.帕金森病的流行病学——概述
J Neural Transm. 1981;51(1-2):135-48. doi: 10.1007/BF01664011.
10
Under-reporting of Parkinson's disease on death certificates: a population-based study (NEDICES).帕金森病在死亡证明上的漏报情况:一项基于人群的研究(NEDICES)
J Neurol Sci. 2014 Dec 15;347(1-2):188-92. doi: 10.1016/j.jns.2014.08.048. Epub 2014 Oct 2.

引用本文的文献

1
A systematic review and meta-analysis of the prevalence of Parkinson's disease in lower to upper-middle-income countries.对低收入至中高收入国家帕金森病患病率的系统评价和荟萃分析。
NPJ Parkinsons Dis. 2024 Sep 30;10(1):181. doi: 10.1038/s41531-024-00779-y.
2
Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study.艾洛比司他治疗帕金森病合并慢性便秘的疗效和安全性:CONST-PD 研究。
Mov Disord Clin Pract. 2024 Apr;11(4):352-362. doi: 10.1002/mdc3.13972. Epub 2024 Jan 24.
3
Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants - Implications for Parkinson's Disease.
环境毒物致多巴胺能神经元易损性的性别差异-对帕金森病的启示。
Curr Environ Health Rep. 2022 Dec;9(4):563-573. doi: 10.1007/s40572-022-00380-6. Epub 2022 Oct 6.
4
Clinical Association between Gout and Parkinson's Disease: A Nationwide Population-Based Cohort Study in Korea.韩国全国范围内基于人群的队列研究:痛风与帕金森病的临床关联。
Medicina (Kaunas). 2021 Nov 24;57(12):1292. doi: 10.3390/medicina57121292.
5
The effect of Non-Motor symptoms on Health-Related quality of life in patients with young onset Parkinson's Disease: A single center Vietnamese Cross-Sectional study.非运动症状对早发性帕金森病患者健康相关生活质量的影响:一项越南单中心横断面研究。
Clin Park Relat Disord. 2021 Nov 24;5:100118. doi: 10.1016/j.prdoa.2021.100118. eCollection 2021.
6
Trends in the incidence and prevalence of Parkinson's disease in Korea: a nationwide, population-based study.韩国帕金森病发病率和患病率的趋势:一项全国性、基于人群的研究。
BMC Geriatr. 2019 Nov 21;19(1):320. doi: 10.1186/s12877-019-1332-7.
7
Prevalence and incidence of Parkinson's disease and drug-induced parkinsonism in Korea.韩国帕金森病和药物诱导性帕金森病的患病率和发病率。
BMC Public Health. 2019 Oct 22;19(1):1328. doi: 10.1186/s12889-019-7664-6.
8
A door-to-door survey to estimate the prevalence of Parkinsonism in Pakistan.一项旨在估算巴基斯坦帕金森症患病率的挨家挨户调查。
Neuropsychiatr Dis Treat. 2016 Jun 21;12:1499-506. doi: 10.2147/NDT.S86329. eCollection 2016.
9
Systematic review of the prevalence and incidence of Parkinson's disease in the People's Republic of China.中华人民共和国帕金森病患病率与发病率的系统评价。
Neuropsychiatr Dis Treat. 2015 Jun 15;11:1467-72. doi: 10.2147/NDT.S85380. eCollection 2015.
10
Drug-induced dyskinesia in Parkinson's disease. Should success in clinical management be a function of improvement of motor repertoire rather than amplitude of dyskinesia?药物诱发的帕金森病运动障碍。临床管理的成功是否应取决于运动障碍幅度的改善,而不是运动障碍的改善?
BMC Med. 2013 Mar 20;11:76. doi: 10.1186/1741-7015-11-76.